MedPath

Graviton Bioscience Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

GV101 in Healthy Obese Participants

Phase 2
Recruiting
Conditions
Weight Management
Interventions
Drug: GV101 placebo
First Posted Date
2025-05-20
Last Posted Date
2025-07-08
Lead Sponsor
Graviton Bioscience Corporation
Target Recruit Count
130
Registration Number
NCT06979505
Locations
🇺🇸

Lakeview Clinical Research, LLC, Guntersville, Alabama, United States

🇺🇸

Catalina Research Institute, LLC, Montclair, California, United States

🇺🇸

Encompass Clinical Research, Spring Valley, California, United States

and more 16 locations

Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects

Phase 1
Completed
Conditions
Phase 1
Interventions
Drug: Placebo
First Posted Date
2021-10-06
Last Posted Date
2023-10-17
Lead Sponsor
Graviton Bioscience Corporation
Target Recruit Count
16
Registration Number
NCT05068947
Locations
🇺🇸

Clinical Pharmacology of Miami, Hialeah, Florida, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath